Antibiotic Regulatory Affairs

Regulatory affairs (RA), also called government affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices etc. Regulatory affairs also have a very specific meaning within the healthcare industries (pharmaceuticals, medical devices, biologics and functional foods). Regulatory affairs (medical affairs) professionals (aka regulatory professionals) usually have responsibility for the following general areas: Ensuring that their companies comply with all of the regulations and laws pertaining to their business. Working with federal, state, and local regulatory agencies and personnel on specific issues affecting their business. i.e. working with such agencies as the Food and Drug Administration or European Medicines Agency (pharmaceuticals and medical devices)

The regulatory function in healthcare industries is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.

Regulatory professionals are employed in industry, government and academia and are involved with a wide range of products, including:

·         Pharmaceuticals

·         Medical devices

·         In vitro diagnostics

·         Biologics and biotechnology

·         Nutritional products

·         Cosmetics

·         Veterinary products

The CDC reports that antibiotic-resistant infections account for at least $20 billion in excess direct health care costs and up to $35 billion in lost productivity due to hospitalizations and sick days each year. The $1.2 billion investment increases funding for antibiotic resistance across the government in FY 2016.  For example, the Budget: Proposes an almost $1 billion investment in FY 2016 – nearly double the 2015 funding level –  for the Department of Health and Human Services (HHS), including:  More than $650 million across the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA) to significantly expand America’s investments in development of antibacterial and new rapid diagnostics, and to launch a large scale effort to characterize drug resistance.  Earlier this year, NIH-supported scientists developed a novel technique for extracting powerful antibiotics from soil, including teixobactin: the first new antibiotic to be discovered in more than 25 years.  The FY 2016 investment increases support for this kind of innovative research and discovery.  More than $280 million at the CDC to support antibiotic stewardship, outbreak surveillance, antibiotic use and resistance monitoring, and research and development related to combating antibiotic resistance.  $47 million at the Food and Drug Administration (FDA) to support evaluation of new antibacterial drugs for patient treatments and antibiotic stewardship in animal agriculture. Nearly quadruples antibiotic research and surveillance funding at the Department of Agriculture (USDA) to $77 million. Increases funding at the Departments of Veterans Affairs (VA) and Defense (DoD) to $85 and $75 million, respectively, to address issues related to antibiotic resistance in healthcare settings.

 

  • National and International laws
  • Frame work of new laws (International understanding)
  • Different systems of operating laws (communication between market and officer desk)

Related Conference of Antibiotic Regulatory Affairs

June 26-28, 2017

9th Annual European Pharma Congress

Madrid, Spain
July 06-07, 2017

8th Global Pharmacovigilance & Drug Safety Summit

Kuala Lumpur, Malaysia
July 17-18, 2017

9th World Congress on BA/BE Studies and Biowaivers

Melbourne, Australia
July 24-25, 2017

8th World Congress on Pharmacology and Toxicology

Melbourne, Australia
July 31-Aug 02, 2017

7th Global Experts Meeting on Neuropharmacology

Milan, Italy
July 31-August 01, 2017

Analytical and Bio-Analytical Techniques Congress

Melbourne, Australia
August 07-09, 2017

4th World Congress on Chromatography

Rome, Italy
August 31-September 01, 2017,

3rd International Conference on Biopharmaceutics and Biologic Drugs

Philadelphia, USA
(10 Plenary Forums - 1Event)
August 31-September 01, 2017

5th International Pharmacy Conference


(10 Plenary Forums - 1 Event)
Philadelphia, USA
September 04-06, 2017

9th World Congress on Pharmacology

Paris, France
September 11-13, 2017

4th International Conference on Clinical Trials

San Antonio, Texas, USA
(10 Plenary Forums - 1 Event)
September 11-12, 2017

World Congress on Biotherapeutics and Bioanalytical Techniques

(10 Plenary Forums - 1Event) Dallas, Texas, USA
September 18-19, 2017

6th International Conference on Forensic Research & Technology

(10 Plenary Forums - 1Event)
Houston, Texas, USA
Sep 25-26, 2017

12th Annual
Pharma Middle East Congress

Dubai, UAE
October 02-03, 2017

9th Annual Pharmaceutical Chemical Analysis Congress

Vienna, Austria
October 09-11, 2017

Global Experts Meeting on Case Reports

Osaka, Japan
October 16-17, 2017

16th Annual Medicinal & Pharmaceutical Sciences Congress

Seoul, South Korea
October 16-18, 2017
(10 Plenary Forums - 1 Event)

4th International Conference on Past and Present Research Systems of Green Chemistry

Atlanta, Georgia, USA
October 18-19, 2017

6th Global Congress on Mass Spectrometry

Osaka, Japan
October 19-20, 2017

9th Annual Congress on Drug Design & Drug Formulation

Seoul, South Korea
October 19-20, 2017

4th International Conference and Exhibition on Pain Medicine

(10 Plenary Forums - 1 Event)
San Francisco, California, USA
(10 Plenary Forums - 1 Event) October 23-24, 2017

5th International Conference on Clinical Pharmacy and Healthcare IT

Orlando, Florida, USA
October 30-November 01, 2017
A B2B Networking & Global Knowledge Exchange Forum

Annual Congress on Emerging Orphan Drugs and  Rare Diseases

San Antonio, Texas, USA
November 13-14, 2017

Global Experts Meeting on Toxicology

Singapore
November 23-24, 2017

Annual Meeting on Pharmacology

Dubai, UAE
Mar 19-20, 2018

International Meeting on Nutraceuticals

Singapore
April 26-27, 2018

11th European Biosimilars Congress

Rome, Italy
July 16-18, 2018

15th Asia-Pacific Pharma Congress

Melbourne, Australia
March 28-29, 2018

11th Annual Congress on Pharmacovigilance and Clinical Trials

Orlando, Florida, USA

Antibiotic Regulatory Affairs Conference Speakers

Recommended Sessions

Related Journals

Are you interested in